In Brazil, analysts expect sharp competition, with prices likely to erode 6070%, translating into annual revenues of $4050 million per player
As in many other fields, obesity medicine aspires to become precision medicine, and this is where the vast array of drugs in development could prove useful
They are particularly valuable for individuals with dietary restrictions or absorption issues who may not receive adequate B-12 from their diet alone
Hetero, Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd, Intas Pharmaceuticals, Cipla, Emcure Pharmaceuticals Limited & Lupin are expected to launch generic versions of semaglutide by March
Some healthcare professionals may recommend gradual dose reduction to allow time for alternative management strategies and smoother metabolic transition
You know, we have many more coming into clinical trials